This study aimed to assess the prognostic value of intratumoral CD57+ cells in head and neck squamous cell carcinoma (HNSCC) and to examine the reproducibility of these analyses using QuPath. The gene discussed is B3GAT1; the disease is head and neck squamous cell carcinoma.